Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Axl-dependent signalling: a clinical update.

Korshunov VA.

Clin Sci (Lond). 2012 Apr;122(8):361-8. doi: 10.1042/CS20110411. Review.

PMID:
22187964
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.

Brown JE, Krodel M, Pazos M, Lai C, Prieto AL.

PLoS One. 2012;7(5):e36800. doi: 10.1371/journal.pone.0036800. Epub 2012 May 14.

PMID:
22606290
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.

Ammoun S, Provenzano L, Zhou L, Barczyk M, Evans K, Hilton DA, Hafizi S, Hanemann CO.

Oncogene. 2014 Jan 16;33(3):336-46. doi: 10.1038/onc.2012.587. Epub 2013 Jan 14.

PMID:
23318455
[PubMed - indexed for MEDLINE]
4.

Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.

Hurtado B, Muñoz X, Recarte-Pelz P, García N, Luque A, Krupinski J, Sala N, García de Frutos P.

Thromb Haemost. 2011 May;105(5):873-82. doi: 10.1160/TH10-10-0630. Epub 2011 Mar 8.

PMID:
21384080
[PubMed - indexed for MEDLINE]
5.

Targeting Axl and Mer kinases in cancer.

Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S.

Mol Cancer Ther. 2011 Oct;10(10):1763-73. doi: 10.1158/1535-7163.MCT-11-0116. Epub 2011 Sep 20. Review.

PMID:
21933973
[PubMed - indexed for MEDLINE]
Free Article
6.

Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.

Weinger JG, Omari KM, Marsden K, Raine CS, Shafit-Zagardo B.

Am J Pathol. 2009 Jul;175(1):283-93. doi: 10.2353/ajpath.2009.080807. Epub 2009 Jun 18.

PMID:
19541935
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.

Hafizi S, Dahlbäck B.

FEBS J. 2006 Dec;273(23):5231-44. Epub 2006 Oct 25. Review.

PMID:
17064312
[PubMed - indexed for MEDLINE]
8.

Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.

Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK.

J Immunol. 2007 May 1;178(9):5635-42.

PMID:
17442946
[PubMed - indexed for MEDLINE]
Free Article
9.

The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.

Hafizi S, Gustafsson A, Stenhoff J, Dahlbäck B.

Int J Biochem Cell Biol. 2005 Nov;37(11):2344-56.

PMID:
15964779
[PubMed - indexed for MEDLINE]
10.

Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis.

Lee WP, Wen Y, Varnum B, Hung MC.

Oncogene. 2002 Jan 17;21(3):329-36.

PMID:
11821945
[PubMed - indexed for MEDLINE]
Free Article
11.

NGF-induced Tyro3 and Axl function as survival factors for differentiating PC12 cells.

Zheng Y, Zhang L, Lu Q, Wang X, Yu F, Wang X, Lu Q.

Biochem Biophys Res Commun. 2009 Jan 16;378(3):371-5. doi: 10.1016/j.bbrc.2008.11.049. Epub 2008 Nov 24.

PMID:
19027714
[PubMed - indexed for MEDLINE]
12.

AXL regulates mesothelioma proliferation and invasiveness.

Ou WB, Corson JM, Flynn DL, Lu WP, Wise SC, Bueno R, Sugarbaker DJ, Fletcher JA.

Oncogene. 2011 Apr 7;30(14):1643-52. doi: 10.1038/onc.2010.555. Epub 2010 Dec 6.

PMID:
21132014
[PubMed - indexed for MEDLINE]
13.

Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.

Hafizi S, Dahlbäck B.

Cytokine Growth Factor Rev. 2006 Aug;17(4):295-304. Epub 2006 Jun 5. Review.

PMID:
16737840
[PubMed - indexed for MEDLINE]
14.

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

Sensi M, Catani M, Castellano G, Nicolini G, Alciato F, Tragni G, De Santis G, Bersani I, Avanzi G, Tomassetti A, Canevari S, Anichini A.

J Invest Dermatol. 2011 Dec;131(12):2448-57. doi: 10.1038/jid.2011.218. Epub 2011 Jul 28.

PMID:
21796150
[PubMed - indexed for MEDLINE]
Free Article
15.

Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.

Mishra A, Wang J, Shiozawa Y, McGee S, Kim J, Jung Y, Joseph J, Berry JE, Havens A, Pienta KJ, Taichman RS.

Mol Cancer Res. 2012 Jun;10(6):703-12. doi: 10.1158/1541-7786.MCR-11-0569. Epub 2012 Apr 19.

PMID:
22516347
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.

Gustafsson A, Boström AK, Ljungberg B, Axelson H, Dahlbäck B.

PLoS One. 2009 Oct 30;4(10):e7575. doi: 10.1371/journal.pone.0007575.

PMID:
19888345
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.

Avilla E, Guarino V, Visciano C, Liotti F, Svelto M, Krishnamoorthy G, Franco R, Melillo RM.

Cancer Res. 2011 Mar 1;71(5):1792-804. doi: 10.1158/0008-5472.CAN-10-2186. Epub 2011 Feb 22.

PMID:
21343401
[PubMed - indexed for MEDLINE]
Free Article
18.

Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells.

Wu YM, Robinson DR, Kung HJ.

Cancer Res. 2004 Oct 15;64(20):7311-20.

PMID:
15492251
[PubMed - indexed for MEDLINE]
Free Article
19.

Molecular pathways: MERTK signaling in cancer.

Cummings CT, Deryckere D, Earp HS, Graham DK.

Clin Cancer Res. 2013 Oct 1;19(19):5275-80. doi: 10.1158/1078-0432.CCR-12-1451. Epub 2013 Jul 5. Review.

PMID:
23833304
[PubMed - indexed for MEDLINE]
20.

Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis.

He L, Zhang J, Jiang L, Jin C, Zhao Y, Yang G, Jia L.

Mol Carcinog. 2010 Oct;49(10):882-91. doi: 10.1002/mc.20664.

PMID:
20635370
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk